Winslow Evans & Crocker’s VivoSim Labs VIVS Stock Holding History

Winslow Evans & Crocker’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	-$1.11K	–	1298
2017 Q1	$1.11K	Hold	1	–	–	﹤0.01%	1181
2016 Q4	$1.19K	Hold	1	–	–	﹤0.01%	1182
2016 Q3	$1.33K	Hold	1	–	–	﹤0.01%	1213
2016 Q2	$1.3K	Hold	1	–	–	﹤0.01%	1200
2016 Q1	$760	Hold	1	–	–	﹤0.01%	1223
2015 Q4	$872	Hold	1	–	–	﹤0.01%	1297
2015 Q3	$938	Hold	1	–	–	﹤0.01%	1224
2015 Q2	$1.32K	Hold	1	–	–	﹤0.01%	1229
2015 Q1	$1.24K	Hold	1	–	–	﹤0.01%	1202
2014 Q4	$2.54K	Hold	1	–	–	﹤0.01%	1173
2014 Q3	$2.23K	Hold	1	–	–	﹤0.01%	1261
2014 Q2	$2.92K	Hold	1	–	–	﹤0.01%	1146
2014 Q1	$2.29K	Hold	1	–	–	﹤0.01%	1152
2013 Q4	$3K	Buy	+1	New	+$1.96K	﹤0.01%	1247

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Winslow Evans & Crocker's VIVS Position: Q2 2017 in Review

Winslow Evans & Crocker sold out of VivoSim Labs (VIVS) in Q2 2017, closing a stake of 1 share — an estimated $1.11K sold.

Winslow Evans & Crocker first reported a position in VIVS in Q4 2013 and held it in 14 quarters. The position peaked at $3K in Q4 2013. 117 funds tracked by Wall St. Rank hold VIVS as of Q2 2017.

Winslow Evans & Crocker reported no remaining VivoSim Labs position as of Q2 2017 after selling out during the quarter.
Winslow Evans & Crocker sold 1 VivoSim Labs share in Q2 2017, an estimated $1.11K.
Winslow Evans & Crocker first reported a position in VivoSim Labs in Q4 2013 and held it in 14 quarters.
Winslow Evans & Crocker's VivoSim Labs position peaked at $3K in Q4 2013.
117 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2017.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.